AMETEK (NYSE:AME - Free Report) had its target price hoisted by Mizuho from $190.00 to $200.00 in a research note issued to investors on Friday, Benzinga reports. Mizuho currently has an outperform rating on the technology company's stock.
Several other research firms have also recently commented on AME. Royal Bank of Canada lowered their target price on shares of AMETEK from $216.00 to $215.00 and set an "outperform" rating for the company in a research note on Friday, August 2nd. Robert W. Baird lowered their price objective on AMETEK from $171.00 to $166.00 and set a "neutral" rating for the company in a research report on Wednesday, August 7th. StockNews.com downgraded AMETEK from a "buy" rating to a "hold" rating in a research report on Tuesday, August 6th. Truist Financial lifted their price target on AMETEK from $219.00 to $221.00 and gave the company a "buy" rating in a report on Friday. Finally, Redburn Atlantic raised shares of AMETEK to a "strong-buy" rating in a research report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $195.00.
View Our Latest Analysis on AME
AMETEK Price Performance
Shares of NYSE AME traded down $4.91 on Friday, hitting $178.43. The company's stock had a trading volume of 1,960,462 shares, compared to its average volume of 1,144,114. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.26 and a quick ratio of 0.76. The stock has a 50 day moving average of $169.17 and a 200-day moving average of $168.99. AMETEK has a 12-month low of $141.26 and a 12-month high of $186.32. The company has a market capitalization of $41.31 billion, a price-to-earnings ratio of 31.09, a price-to-earnings-growth ratio of 2.77 and a beta of 1.17.
AMETEK (NYSE:AME - Get Free Report) last announced its earnings results on Thursday, October 31st. The technology company reported $1.66 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.04. AMETEK had a return on equity of 17.41% and a net margin of 19.51%. The firm had revenue of $1.71 billion for the quarter, compared to analysts' expectations of $1.71 billion. During the same quarter in the prior year, the firm earned $1.64 EPS. AMETEK's quarterly revenue was up 5.3% on a year-over-year basis. As a group, research analysts predict that AMETEK will post 6.76 EPS for the current year.
AMETEK Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were issued a dividend of $0.28 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $1.12 annualized dividend and a dividend yield of 0.63%. AMETEK's payout ratio is 19.51%.
Insider Activity at AMETEK
In other AMETEK news, Director Steven W. Kohlhagen sold 1,460 shares of the business's stock in a transaction dated Wednesday, September 25th. The stock was sold at an average price of $171.59, for a total transaction of $250,521.40. Following the transaction, the director now owns 23,349 shares in the company, valued at $4,006,454.91. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.61% of the stock is owned by insiders.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. EverSource Wealth Advisors LLC raised its position in shares of AMETEK by 7.3% in the 1st quarter. EverSource Wealth Advisors LLC now owns 899 shares of the technology company's stock valued at $157,000 after purchasing an additional 61 shares in the last quarter. MorganRosel Wealth Management LLC boosted its stake in AMETEK by 1.6% during the 2nd quarter. MorganRosel Wealth Management LLC now owns 3,886 shares of the technology company's stock valued at $648,000 after acquiring an additional 61 shares during the last quarter. Commerzbank Aktiengesellschaft FI increased its position in shares of AMETEK by 4.8% in the 2nd quarter. Commerzbank Aktiengesellschaft FI now owns 1,340 shares of the technology company's stock worth $224,000 after purchasing an additional 61 shares during the last quarter. First Horizon Advisors Inc. raised its stake in shares of AMETEK by 2.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 2,639 shares of the technology company's stock valued at $440,000 after purchasing an additional 62 shares in the last quarter. Finally, Checchi Capital Advisers LLC lifted its position in shares of AMETEK by 2.9% during the second quarter. Checchi Capital Advisers LLC now owns 2,225 shares of the technology company's stock worth $371,000 after purchasing an additional 63 shares during the last quarter. 87.43% of the stock is owned by institutional investors and hedge funds.
About AMETEK
(
Get Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Read More
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.